20 May 2013
Keywords: product, license, news, brief, cenes, uk, biopharmaceutical
Article | 20 November 1997
- CeNeS, a UK biopharmaceutical company, has signed a license agreementwith BTG plc for the worldwide rights to develop a new ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.